Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,116 | 14,400 | 14,764 | 22,494 | 23,350 |
| Receivables | 143,150 | 140,605 | 120,755 | 152,898 | 208,143 |
| Inventories | 45,664 | 33,317 | 33,720 | 40,906 | 43,371 |
| Other current assets | 13,696 | 6,513 | 6,511 | 10,196 | 12,710 |
| TOTAL | $230,977 | $207,427 | $186,461 | $238,547 | $301,820 |
| Non-Current Assets | |||||
| PPE Net | 122,917 | 123,098 | 129,882 | 143,211 | 149,014 |
| Intangibles | 232,466 | 188,440 | 188,980 | 188,200 | 175,106 |
| Other Non-Current Assets | 62,467 | 65,847 | 67,729 | 55,300 | 47,385 |
| TOTAL | $417,850 | $377,385 | $386,591 | $386,711 | $371,505 |
| Total Assets | $648,827 | $584,812 | $573,052 | $625,258 | $673,325 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,155 | 41,697 | 33,720 | 33,474 | 47,084 |
| Accrued Expenses | 22,549 | 28,887 | 19,411 | 36,475 | 34,617 |
| Other current liabilities | 11,113 | 9,227 | 13,668 | 25,480 | 19,624 |
| TOTAL | $102,547 | $100,576 | $104,023 | $120,758 | $131,866 |
| Non-Current Liabilities | |||||
| Long Term Debt | 289,770 | 226,989 | 216,488 | 430,987 | 353,672 |
| Deferred Revenues | 17,325 | 12,627 | 15,690 | 14,101 | 11,009 |
| Other Non-Current Liabilities | 87,713 | 103,221 | 91,003 | 92,246 | 85,443 |
| TOTAL | $385,380 | $335,504 | $313,732 | $528,199 | $447,466 |
| Total Liabilities | $487,927 | $436,080 | $417,755 | $648,957 | $579,332 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,317 | 44,164 | 44,152 | 42,376 | 43,322 |
| Common Shares | 1,148 | 1,148 | 1,148 | 1,142 | 1,174 |
| Retained earnings | 156,130 | 173,855 | 187,957 | 219,207 | 415,906 |
| Other shareholders' equity | -816 | -4,734 | -5,658 | -5,048 | -5,087 |
| TOTAL | $160,900 | $148,732 | $155,297 | $-23,699 | $93,993 |
| Total Liabilities And Equity | $648,827 | $584,812 | $573,052 | $625,258 | $673,325 |